Market Tracker

07/24 6:05pm ET

Synageva BioPharma Corp (NASDAQ:GEVA)

During the Trading Day
75.24 +2.80 / +3.87%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
72.44 -2.80 / -3.72%
 
Volume: 172.2K
No recent news for Synageva BioPharma Corp.

Today’s Trading

Previous close72.44
Today’s open72.50
Day’s range72.27 - 76.61
Volume431,762
Average volume (3 months)282,738
Market cap$2.4B
Dividend yield--
Data as of 4:00pm ET, 07/24/2014

Growth & Valuation

Earnings growth (last year)-78.95%
Earnings growth (this year)-74.26%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)-10.57%
P/E ratioNM
Price/Sales135.92
Price/Book5.18

Competitors

 Today’s
change
Today’s
% change
XONIntrexon Corp+0.42+1.78%
OPHTOphthotech Corp-0.63-1.55%
HALOHalozyme Therapeutic...-0.09-0.97%
NVAXNovavax Inc-0.07-1.54%
Data as of 4:07pm ET, 07/24/2014

Financials

Next reporting dateJuly 31, 2014
EPS forecast (this quarter)-$1.37
Annual revenue (last year)$13.4M
Annual profit (last year)-$95.5M
Net profit margin-713.70%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Sanj K. Patel
Chief Financial Officer &
Senior Vice President
Carsten Boess
Corporate headquarters
Lexington, Massachusetts

Forecasts